| Ident. | Authors (with country if any) | Title |
|---|
| 000357 (2006) |
Wolfgang H. Oertel [Allemagne] ; Erik Wolters [Pays-Bas] ; Cristina Sampaio [Portugal] ; Santiago Gimenez-Roldan [Espagne] ; Bruno Bergamasco [Italie] ; Max Dujardin [France] ; Donald G. Grosset [Royaume-Uni] ; Guy Arnold [Allemagne] ; Klaus L. Leenders [Pays-Bas] ; Hans-Peter Hundemer [États-Unis] ; Alberto Lled [États-Unis] ; Andrew Wood [États-Unis] ; Paul Frewer [États-Unis] ; Johannes Schwarz [Allemagne] | Pergolide versus levodopa monotherapy in early Parkinson's disease patients: The PELMOPET study |
| 000358 (2006) |
Claire Ardouin [France] ; Valerie Voon [Canada] ; Yulia Worbe [France] ; Nehman Abouazar [France] ; Virginie Czernecki [France] ; Hassan Hosseini [France] ; Antoine Pelissolo [France] ; Elena Moro [Canada] ; Eugénie Lhommée [France] ; Anthony E. Lang [Canada] ; Yves Agid [France] ; Alim-Louis Benabid [France] ; Pierre Pollak [France] ; Luc Mallet [France] ; Paul Krack [France] | Pathological gambling in Parkinson's disease improves on chronic subthalamic nucleus stimulation |
| 000364 (2006) |
Emmanuel Roze [France] ; Maria Clara Coêlho-Braga [France] ; Dominique Gayraud [France] ; André Pierre Legrand [France] ; Jean-Marc Trocello [France] ; Gilles Fénelon [France] ; Valérie Cochen [France] ; Nathalie Patte [France] ; François Viallet [France] ; Marie Vidailhet [France] ; Pierre Pollak [France] ; Emmanuelle Apartis [France] | Head tremor in Parkinson's disease |
| 000366 (2006) |
Robert E. Gross [États-Unis] ; Paul Krack [France] ; Maria C. Rodriguez-Oroz [Espagne] ; Ali R. Rezai [États-Unis] ; Alim-Louis Benabid [France] | Electrophysiological mapping for the implantation of deep brain stimulators for Parkinson's disease and tremor |
| 000368 (2006) |
Aurélie Funkiewiez [France] ; Claire Ardouin [France] ; Roshan Cools [Royaume-Uni] ; Paul Krack [France] ; Valérie Fraix [France] ; Alina Batir [France] ; Stephan Chabardès [France] ; Alim-Louis Benabid [France] ; Trevor W. Robbins [Royaume-Uni] ; Pierre Pollak [France] | Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease |
| 000369 (2006) |
Olivier Rascol [France] ; Bruno Dubois [France] ; Alexandre Castro Caldas [Portugal] ; Stephen Senn [Royaume-Uni] ; Susanna Del Signore [France] ; Andrew Lees (neurologue) [Royaume-Uni] | Early piribedil monotherapy of Parkinson's disease: A planned seven‐month report of the REGAIN study |
| 000371 (2006) |
Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni] | Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa |
| 000374 (2006) |
Anthony E. Lang [Canada] ; Jean-Luc Houeto [France] ; Paul Krack [France] ; Cynthia Kubu [États-Unis] ; Kelly E. Lyons [États-Unis] ; Elena Moro [Canada] ; William Ondo [États-Unis] ; Rajesh Pahwa [États-Unis] ; Werner Poewe [Autriche] ; Alexander I. Tröster [États-Unis] ; Ryan Uitti [États-Unis] ; Valerie Voon [Canada, États-Unis] | Deep brain stimulation: Preoperative issues |
| 000375 (2006) |
Valerie Voon [Canada, États-Unis] ; Cynthia Kubu [États-Unis] ; Paul Krack [France] ; Jean-Luc Houeto [France] ; Alexander I. Tröster [États-Unis] | Deep brain stimulation: Neuropsychological and neuropsychiatric issues |
| 000377 (2006) |
Andre Machado [États-Unis] ; Ali R. Rezai [États-Unis] ; Brian H. Kopell [États-Unis] ; Robert E. Gross [États-Unis] ; Ashwini D. Sharan [États-Unis] ; Alim-Louis Benabid [France] | Deep brain stimulation for Parkinson's disease: Surgical technique and perioperative management |
| 000378 (2006) |
Ali R. Rezai [États-Unis] ; Brian H. Kopell [États-Unis] ; Robert E. Gross [États-Unis] ; Jerrold L. Vitek [États-Unis] ; Ashwini D. Sharan [États-Unis] ; Patricia Limousin [Royaume-Uni] ; Alim-Louis Benabid [France] | Deep brain stimulation for Parkinson's disease: Surgical issues |
| 000381 (2006) |
Roberta Frigerio [États-Unis] ; Kevin R. Sanft [États-Unis] ; Brandon R. Grossardt [États-Unis] ; Brett J. Peterson [États-Unis] ; Alexis Elbaz [France] ; James H. Bower [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Mariza De Andrade [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Walter A. Rocca [États-Unis] | Chemical exposures and Parkinson's disease: A population‐based case–control study |
| 000383 (2006) |
Michael P. Hill [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni] ; Steven G. Mcguire [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni, Canada] ; Alan R. Crossman [Royaume-Uni] ; Catherine Rochat [France] ; Mark J. Millan [France] | Antiparkinsonian effects of the novel D3/D2 dopamine receptor agonist, S32504, in MPTP‐lesioned marmosets: Mediation by D2, not D3, dopamine receptors |
| 000384 (2006) |
Alexandre Castro-Caldas [Portugal] ; Paul Delwaide [Belgique] ; Wolfgang Jost [Allemagne] ; Marcelo Merello [Argentine] ; Adrian Williams [Royaume-Uni] ; Paolo Lamberti [Italie] ; Miguel Aguilar [Espagne] ; Susanna Del Signore [France] ; Pierre Cesaro [France] | The parkinson-control study : A 1-year randomized, double- blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in parkinson's disease |
| 000395 (2005) |
Alexis Elbaz [États-Unis, France] ; Brett J. Peterson [États-Unis] ; James H. Bower [États-Unis] ; Ping Yang [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Shannon K. Mcdonnell [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Walter A. Rocca [États-Unis] | Risk of cancer after the diagnosis of Parkinson's disease: A historical cohort study |
| 000397 (2005) |
Pierre Champy [France] ; Alice Melot [France] ; Vincent Guérineau Eng [France] ; Christophe Gleye [France] ; Djibril Fall [France, Sénégal] ; Gunter U. Höglinger [France] ; Merle Ruberg [France] ; Annie Lannuzel [France] ; Olivier Laprévote [France] ; Alain Laurens [France] ; Reynald Hocquemiller [France] | Quantification of acetogenins in Annona muricata linked to atypical parkinsonism in guadeloupe |
| 000400 (2005) |
Stéphane Chapuis [France] ; Lemlih Ouchchane [France] ; Olivier Metz [France] ; Laurent Gerbaud [France] ; Franck Durif [France] | Impact of the motor complications of Parkinson's disease on the quality of life |
| 000402 (2005) |
Anne Doé De Maindreville [France] ; Gilles Fénelon [France] ; Florence Mahieux [France] | Hallucinations in Parkinson's disease: A follow‐up study |
| 000404 (2005) |
Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] | Evidence‐based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004 |
| 000406 (2005) |
Nicolas Simon [France] ; Joëlle Micallef [France] ; Jean-Charles Reynier [France] ; Monique Lesourd [France] ; Tatiana Witjas [France] ; André Alicherif [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] | End‐of‐dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: A pharmacokinetic/pharmacodynamic, randomized, double‐blind study |
| 000409 (2005) |
Alexandre Kreisler [France] ; Luc Defebvre [France] ; Pascal Lecouffe [France] ; Alain Duhamel [France] ; Pierre Charpentier [France] ; Marc Steinling [France] ; Alain Destée [France] | Corticobasal degeneration and Parkinson's disease assessed by HmPaO SPECT: The utility of factorial discriminant analysis |
